COMMUNIQUÉS West-GlobeNewswire

-
Ensho Therapeutics Announces Upcoming Presentation at ECCO 2025 of Phase 1, Once-Daily Dosing Data for NSHO-101, an Oral α4β7 Inhibitor for Inflammatory Bowel Disease
14/02/2025 - 15:00 -
Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025
14/02/2025 - 15:05 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
14/02/2025 - 15:15 -
AVITA Medical to Host Investor Webinar Briefing
14/02/2025 - 15:15 -
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity
14/02/2025 - 17:52 -
Zus Health Celebrates Unprecedented Growth, Announcing New Clients and AI-Powered Innovations
14/02/2025 - 18:33 -
Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency
14/02/2025 - 19:16 -
PetVivo Reports Fiscal Q3 2025 Results
14/02/2025 - 21:10 -
Turmeric Hack: The 15-Second Morning Ritual Transforming Weight Loss, Backed by Doctor Julian Ross
14/02/2025 - 21:12 -
New AI-Powered Startup Merges Technology and Holistic Wellness to Deliver Personalized Health Solutions
14/02/2025 - 21:45 -
MEDIA ADVISORY - Patients who have been extra-billed for surgeries in private for-profit clinics demand accountability in the Ontario election: Press conferences in towns across Ontario
14/02/2025 - 21:55 -
Entero Therapeutics Appoints Richard Paolone as CEO
14/02/2025 - 22:00 -
Fate Therapeutics to Present at Upcoming Investor Conferences
14/02/2025 - 22:01 -
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/02/2025 - 22:01 -
NurExone Biologic Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation
14/02/2025 - 22:03 -
Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
14/02/2025 - 22:05 -
GENFIT annonce la modification des termes définitifs de la double proposition aux porteurs d’OCEANEs 2025
14/02/2025 - 22:10 -
GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
14/02/2025 - 22:10 -
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
14/02/2025 - 22:15
Pages